drugset / Trial / NCT01635088

Onset and Duration of Mometasone by Oscillometry and Spirometry

NCT01635088

RandomizedSingle-groupOpen-labelTreatment

Summary

Inhaled corticosteroids (ICS) are appreciated for their long term anti-inflammatory effects in chronic asthma. However, they also have largely unappreciated early effects when initiated as a controller therapy in a steroid-naïve population. Impulse oscillometry might reveal such an early effect better than spirometry. The investigators sought to examine the onset of action and sustained effects over 4 weeks treatment of mometasone furoate as measured by Impulse Oscillometry System (IOS) versus spirometry.

Timeline

Start
2011-06
Primary completion
2011-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 220 ug Inhaled
Subject Mometasone furoate Other / unclassified 440 ug Inhaled

Indications